 |
SKNAS Transfection Reagent |
|
|
Catalog # 3259 - 0.5 mL $ 139.00
Catalog # 3260 - 1.5 mL $ 228.00
Transfection reagent for SKNAS cells
- Protocols provided for transfection of siRNA and microRNA
- High transfection efficiency
- Low toxicity
- Work in presence of serum
- Compatible with transfection in any plate format
- Reproducible transfection
- Kit includes Transfection Enhancer reagent and recommended transfection protocols
- Optimized transfection protocols are adapted for use with both standard & reverse transfection methods
- Developed and manufactured by Altogen Biosystems
Transfection Efficiency:
Reagent exhibits at least 90% transfection
efficiency of siRNA delivery. Transfection efficiency
was determined by real-time RT-PCR.
Transfection Protocol:
Transfection protocols are provided with
the purchase of the reagent.
|
 |
DATA |
|
Figure 1. Cyclophilin B silencing efficiency was determined by qRT-PCR in the cells transfected by Cyclophilin B siRNA or non-silencing siRNA control following the recommended transfection protocol. Cyclophilin mRNA expression levels were measured 48 hours post-transfection. 18S rRNA levels were used to normalize the Cyclophilin B data. Values are normalized to untreated sample. Data are presented as means ± SD (n=3).
 |
Transfection Resource |
|
siRNA Transfection || Transfection Methods || Stable Transfection || RNAi || siRNA Library Screening || RNAi Therapeutics || Cell Transfection || In Vivo Transfection Reagents || Cell Line Specific Transfection Reagents
|
Featured Products |
|
In Vivo Transfection Reagents || Fibroblast Cells Transfection Reagent || Astrocyte Cells Transfection Reagent || HEK-293 Transfection Reagent || MEF Transfection Reagent || HepG2 Transfection Reagent || CHO Reagent || MDA-MB Transfection Reagent || Cos7 Transfection Reagent || A549 Transfection Reagent || NIH3T3 Reagent || HUVEC Transfection Reagent || LNCaP Transfection Reagent || MCF-7 Reagent || PC-12 Reagent
|
Altogen Research Services |
|
Altogen Custom Services provide specialized biotechnology and pharmaceutical services, including - generation of stable cell lines, RNA Interference (RNAi) services, assay development, screening and transfection services. Generation of stably-expressing cancer cell lines and primary cells can be very expensive and time-consuming. Altogen Services offers generation of stable cell lines by transforming the cell line of choice to stably express gene of interest or shRNA-encoding construct. Cloning and shRNA expression services are available.
|
